Effect of complement C1q expression on hepatic ischemia-reperfusion injury in rats

Abstract

The effect of the complement C1q expression on total hepatic ischemia-reperfusion (I/R) injury in rats was investigated. Sixty healthy male Sprague Dawley (SD) rats weighing 180–200 g were randomly divided into 5 groups: sham-operation group (S group, n=12); group of I/R for 1 h (I/R 1 h group, n=12); group of I/R for 3 h (I/R 3 h group, n=12); group of I/R for 6 h (I/R 6 h group, n=12); group of I/R for 24 h (I/R 24 h group, n=12). The hepatic I/R model of rats was established, and liver tissues were obtained 1 h, 3 h, 6 h and 24 h after hepatic I/R, respectively. Furthermore, the tissues were stained using hematoxylin-eosin, and the liver injuries of rats were observed using a microscope. The malondialdehyde (MDA) level and superoxide dismutase (SOD) activity in liver tissue were determined. Real-time polymerase chain reaction (PCR) and Western blotting were used to detect the expression levels of C1q mRNA and protein, respectively. As compared with the S group, the histopathological changes in I/R 1 h-24 h groups were gradually aggravated with the extension of I/R time. As compared with the S group, SOD activity and MDA content in the I/R groups were reduced and increased respectively with the extension of I/R time (P<0.01). Furthermore, the C1q expression at mRNA and protein levels in the I/R groups (especially in the I/R 3 h group) was significantly higher than that in the S group (P<0.05). It is suggested that C1q expression may play a principal role in hepatic I/R injury, particularly at the early stage of perfusion.

Keywords

hepatic ischemia-reperfusion / complement system / C1q

References

[1] IsozakiH, OkajimaK, KobayashiM, et al.. Experimental study of liver injury after partial hepatectomy with intermittent or continuous hepatic vascular occlusion. Differences in tolerance to ischemia between normal and cirrhotic livers. Eur Surg Res, 1995, 27(5): 313-322

[2] PocardM, Vincent-SalomonA, GirodetJ, et al.. Effects of preoperative chemotherapy on liver function tests after hepatectomy. Hepatogastroenterology, 2001, 48(41): 1406-1408

[3] MorganBP, HarrisCL. Complement therapeutics: history and current progress. Mol Immunol, 2003, 40(2–4): 159-170

[4] ArumugamTV, MagnusT, WoodruffTM, et al.. Complement mediators in ischemia-reperfusion injury. Clin Chim Acta, 2006, 374(1–2): 33-45

[5] ParasrampuriaR, ShaikIH, MehvarR. Effects of in vivo hepatic ischemia-reperfusion injury on the hepatobiliary disposition of rhodamine 123 and its metabolites in isolated perfused rat livers. J Pharm Pharm Sci, 2012, 15(2): 318-328

[6] MarinoJH, GookP, MillerKS. Accurate and statistically verified quantification of relative mRNA abundances using SYBR Green I and real-time PT-PCR. J Immunol Methods, 2003, 283(1–2): 291-306

[7] TeohNC. Hepatic ischemia reperfusion injury: Contemporary perspectives on pathogenic mechanisms and basis for hepatoprotection—the good, bad and deadly. J Gastroenterol Hepatol, 2011, 26Suppl1: 180-187

[8] LeeH, GreenDJ, LaiL, et al.. Early complement factors in the local tissue immunocomplex generated during intestinal ischemia/reperfusion injury. Mol Immunol, 2010, 47(5): 972-981

[9] SzeplakiG, SzegediR, HirschbergK, et al.. Strong complement activation after acute ischemic stroke is associated with unfavorable outcomes. Atherosclerosis, 2009, 204(1): 315-320

[10] FlemingSD, HyltonD, HoffmanS, et al.. CR2 targeted complement inhibitors attenuate intestinal damage. Mol Immunol, 2010, 47(13): 2277

[11] MaZW, FengXB, ZhengSG, et al.. Ethanol preconditioning reduces hepatic I/R injury by inhibiting the complement system activation. J Surg Res, 2011, 166(2): 314-323